Pneumocystis Jirovecii Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumocystis Jirovecii Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS [NA]
This clinical trial investigates short-term corticosteroid therapy for Pneumocystis jirovecii pneumonia in people with HIV/AIDS; enrollment …
-
FDA approval · 2026-03-20FDA Approved: MEPRON — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved GlaxoSmithKline's supplemental application for Mepron (atovaquone). It updates the drug's labeling and indications under ND…
-
FDA approval · 2026-02-26FDA Approved: DAPSONE — Original Application (Viona Pharmaceuticals Inc)
FDA approved DAPSONE through an Original Application (ANDA) by Viona Pharmaceuticals Inc. The approval covers the generic use of DAPSONE for…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) [Phase 4]
A Phase 4 clinical trial update on second-line therapies for Pneumocystis jirovecii pneumonia, with the study currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: How Long Should we Give Steroids for Patients With Severe PCP [Phase 4]
A Phase 4 clinical trial from McGill University Health Centre is investigating the optimal duration of steroid therapy for severe Pneumocyst…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology
This clinical trial update notes the introduction of PCR methods in microbiology and parasitology, with the study currently recruiting for m…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Corticosteroids for PJP in Non-HIV Immunocompromised Adults [Phase 3]
A Phase 3 clinical trial evaluating the use of corticosteroids for Pneumocystis jirovecii pneumonia in non-HIV immunocompromised adults is n…
-
CLINICAL_TRIALS other · 2025-06-27Clinical Trial Update: Pneumocystis Jirovecii Genotyping
An update on a Nottingham University Hospitals NHS Trust trial investigating Pneumocystis jirovecii genotyping in Pneumocystis pneumonia. Th…
-
FDA approval · 2025-06-17FDA Approved: DAPSONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for DAPSONE submitted by Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Pneumocystis in Patients Over 75 Year
This clinical trial update notes the completion of a study evaluating Pneumocystis infection in patients over 75 years old.
-
FDA approval · 2025-04-23FDA Approved: DAPSONE — Supplemental Application (Seton Pharmaceuticals)
FDA approved a supplemental application for DAPSONE tablets from Seton Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid Organ Transplant Recipients: Potential Involvement of Mycophenolic Acid
This completed clinical trial update examines the genotypes and phenotypes of Pneumocystis jirovecii in solid organ transplant recipients an…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
Completed prospective observational study assessing the incidence of opportunistic fungal infections, including Pneumocystis jirovecii pneum…
-
FDA approval · 2025-02-21FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for sulfamethoxazole and trimethoprim, granting approval of a generic p…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis Jirovecii
A clinical trial evaluating droplet digital PCR and PCR-free biosensors to detect resistance-associated SNPs in Pneumocystis jirovecii causi…
-
FDA approval · 2024-06-24FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for sulfamethoxazole and trimethoprim by Prasco Laboratories. This action confirms the approval of t…
-
FDA approval · 2024-04-02FDA Approved: ATOVAQUONE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for atovaquone.
-
FDA approval · 2023-10-27FDA Approved: DAPSONE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the original application for DAPSONE (dapsone) as a generic drug from Alembic Pharmaceuticals Inc.
-
FDA approval · 2023-05-31FDA Approved: DAPSONE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the Original Application for Dapsone (DAPSONE) by Amneal Pharmaceuticals NY LLC, authorizing a generic version of the drug.
-
FDA approval · 2022-11-22FDA Approved: ATOVAQUONE ORAL SUSPENSION — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application to authorize the Atovaquone oral suspension produced by KVK-Tech, Inc.
-
FDA approval · 2022-03-17FDA Approved: PENTAMIDINE ISETHIONATE — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved the original application for Pentamidine isethionate (generic) from XGen Pharmaceuticals DJB, Inc., authorizing its U.S. market…
-
FDA approval · 2022-02-10FDA Approved: DAPSONE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the original application for DAPSONE (dapsone) as a generic drug manufactured by Torrent Pharmaceuticals Limited.
-
FDA approval · 2021-10-25FDA Approved: ATOVAQUONE — Original Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved the original application for atovaquone, including the oral suspension, from PAI Holdings, LLC dba PAI Pharma, marking approval…
-
FDA approval · 2021-03-30FDA Approved: ATOVAQUONE — Original Application (Bionpharma Inc.)
FDA approved the original ANDA for atovaquone by Bionpharma Inc., authorizing a generic version of the medication.
-
FDA approval · 2021-01-07FDA Approved: PENTAMIDINE ISETHIONATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves an Original Application for Pentamidine isethionate injection as a generic product from Heritage Pharmaceuticals (Avet) Inc.